Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions
Condition:   Bioequivalence Interventions:   Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Test;   Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Reference Sponsors:   World Medicine ILAC SAN. ve TIC. A.S.;   Novagenix Bioanalytical Drug R&D  Center;   Farmagen Ar-Ge Biyot. Ltd. Sti Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2020 Category: Research Source Type: clinical trials

Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
Conditions:   Pulmonary Complications in Surgical Patients;   COVID;   Severe Acute Respiratory Syndrome Interventions:   Drug: Lopinavir-Ritonavir;   Drug: Hydroxychloroquine Sponsors:   University of Birmingham;   Christian Medical College and Hospital, Ludhiana, India;   Tamale Teaching Hospital, Ghana.;   University of Lagos, Nigeria;   Kigali University Teaching Hospital;   Hospital Español Veracruz;   Université d'Abomey-Calavi;   University of Witw atersrand, South Africa;   University of Edinburgh;   Istituto Clinico Humanitas;   University of Cape Town Not yet re...
Source: ClinicalTrials.gov - May 13, 2020 Category: Research Source Type: clinical trials

Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions
Condition:   Bioequivalence Interventions:   Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Test;   Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Reference Sponsors:   World Medicine ILAC SAN. ve TIC. A.S.;   Novagenix Bioanalytical Drug R&D  Center;   Farmagen Ar-Ge Biyot. Ltd. Sti Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2020 Category: Research Source Type: clinical trials

Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
Conditions:   Pulmonary Complications in Surgical Patients;   COVID;   Severe Acute Respiratory Syndrome Interventions:   Drug: Lopinavir-Ritonavir;   Drug: Hydroxychloroquine Sponsors:   University of Birmingham;   Christian Medical College and Hospital, Ludhiana, India;   Tamale Teaching Hospital, Ghana.;   University of Lagos, Nigeria;   Kigali University Teaching Hospital;   Hospital Español Veracruz;   Université d'Abomey-Calavi;   University of Witw atersrand, South Africa;   University of Edinburgh;   Istituto Clinico Humanitas;   University of Cape Town Not yet re...
Source: ClinicalTrials.gov - May 13, 2020 Category: Research Source Type: clinical trials

Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions
Condition:   Bioequivalence Interventions:   Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Test;   Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Reference Sponsors:   World Medicine ILAC SAN. ve TIC. A.S.;   Novagenix Bioanalytical Drug R&D  Center;   Farmagen Ar-Ge Biyot. Ltd. Sti Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2020 Category: Research Source Type: clinical trials